Lipid Metabolism Practice Questions

Q: Which of the following processes occurs during a low insulin to glucagon ratio?

Ketogenesis. **Explanation:** A **low insulin-to-glucagon ratio** signifies a fasting or "starvation" state. In this hormonal milieu, the body shifts from energy storage to energy mobilization. **Why Ketogenesis is Correct:** When insulin is low and glucagon is high, **Hormone-Sensitive Lipase (HSL)** in adipose tissue is activated, leading to massive lipolysis. This floods the liver with free fatty acids (FFAs). Inside the liver, glucagon stimulates **Carnitine Palmitoyltransferase-1 (CPT-1)** by decreasing Malonyl-CoA levels. This allows FFAs to enter the mitochondria for $\beta$-oxidation, resulting in an excess of Acetyl-CoA. Since the TCA cycle is overwhelmed (and oxaloacetate is diverted toward gluconeogenesis), the liver converts this excess Acetyl-CoA into **ketone bodies** (Acetoacetate, $\beta$-hydroxybutyrate) to provide fuel for extrahepatic tissues like the brain. **Why the other options are incorrect:** * **Cholesterol Synthesis (A), Glycogen Synthesis (B), and Fatty Acid Synthesis (D)** are all **anabolic processes** stimulated by **Insulin** (high insulin-to-glucagon ratio). Insulin activates key rate-limiting enzymes: HMG-CoA reductase (cholesterol), Glycogen synthase (glycogen), and Acetyl-CoA Carboxylase (fatty acids) via dephosphorylation. **NEET-PG High-Yield Pearls:** * **Rate-limiting enzyme of Ketogenesis:** HMG-CoA Synthase (Mitochondrial). * **Ketone bodies** are utilized by the brain, heart, and skeletal muscle, but **never by the liver** (due to the absence of the enzyme Thiophorase/$\beta$-ketoacyl-CoA transferase). * **Hormone-Sensitive Lipase (HSL)** is the "starvation enzyme," while **Lipoprotein Lipase (LPL)** is the "feeding enzyme."

Q: In which of the following metabolic disorders is this skin finding characteristically seen?

Fabry disease. ***Fabry disease*** - The skin finding shown is **angiokeratoma corporis diffusum**, which is pathognomonic for Fabry disease and presents in a characteristic **bathing trunk distribution**. - Caused by **alpha-galactosidase A deficiency** leading to **Gb3 accumulation** in blood vessels, resulting in these distinctive dark red, punctate vascular lesions. *Farber disease* - Characterized by **subcutaneous nodules** around joints and **hoarse voice** due to laryngeal involvement, not angiokeratomas. - Results from **acid ceramidase deficiency** causing ceramide accumulation, presenting with joint contractures and granulomatous lesions. *Galactosemia* - Associated with **cataracts**, **hepatomegaly**, and **intellectual disability** rather than characteristic skin lesions. - Caused by **galactose-1-phosphate uridyltransferase deficiency**, leading to galactose accumulation affecting liver, brain, and eyes. *Albinism* - Presents with **hypopigmentation** of skin, hair, and eyes due to **melanin synthesis defects**. - Characterized by **photosensitivity** and **nystagmus**, with no vascular skin lesions like angiokeratomas.

Q: Which of the following classes of lipoproteins transfers cholesterol from membrane turnover?

HDL. **Explanation:** The correct answer is **HDL (High-Density Lipoprotein)**. This process is known as **Reverse Cholesterol Transport (RCT)**. **Why HDL is correct:** HDL acts as a scavenger of cholesterol in the body. When peripheral tissues undergo membrane turnover or have excess intracellular cholesterol, HDL picks up this free cholesterol. This is mediated by the enzyme **LCAT (Lecithin-Cholesterol Acyltransferase)**, which esterifies free cholesterol into cholesterol esters, allowing them to be packed into the HDL core. HDL then transports this cholesterol back to the liver for excretion in bile or repositioning, thus preventing lipid accumulation in the arterial walls. **Why the other options are incorrect:** * **VLDL (Very Low-Density Lipoprotein):** Produced by the liver to transport endogenous triglycerides to peripheral tissues. * **IDL (Intermediate-Density Lipoprotein):** A transient remnant formed during the conversion of VLDL to LDL; it primarily delivers triglycerides and cholesterol to the liver or becomes LDL. * **LDL (Low-Density Lipoprotein):** Known as "bad cholesterol," its primary role is to transport cholesterol **from** the liver **to** peripheral tissues. High levels are associated with atherosclerosis. **High-Yield NEET-PG Pearls:** * **Apo A-I:** The major apoprotein associated with HDL; it activates LCAT. * **ABCA1 Transporter:** Essential for the efflux of cholesterol from cells to nascent HDL. A deficiency leads to **Tangier Disease**. * **CETP (Cholesterol Ester Transfer Protein):** Facilitates the exchange of cholesterol esters from HDL to VLDL/LDL in exchange for triglycerides. * HDL is considered "cardioprotective" because it clears cholesterol from foam cells in atherosclerotic plaques.

Q: Which of the following is a secondary bile acid?

Litocholic acid. ### Explanation Bile acids are steroid acids synthesized from cholesterol in the liver and are essential for the digestion and absorption of dietary fats. They are classified into two categories: **Primary** and **Secondary**. **1. Why Lithocholic Acid is Correct:** **Lithocholic acid** is a **secondary bile acid**. Secondary bile acids are not synthesized by the liver; instead, they are formed in the colon through the action of bacterial enzymes (specifically 7α-dehydroxylase) on primary bile acids. * **Chenodeoxycholic acid** is dehydroxylated by intestinal bacteria to form **Lithocholic acid**. * **Cholic acid** is dehydroxylated to form **Deoxycholic acid**. **2. Why the Other Options are Incorrect:** * **Option A (Cholic acid):** This is a **primary bile acid**. It is synthesized directly from cholesterol in the hepatocytes. It contains three hydroxyl groups (at positions 3, 7, and 12). * **Option B (Chenodeoxycholic acid):** This is also a **primary bile acid** synthesized in the liver. It contains two hydroxyl groups (at positions 3 and 7). **3. NEET-PG High-Yield Clinical Pearls:** * **Rate-Limiting Step:** The conversion of cholesterol to 7α-hydroxycholesterol by the enzyme **7α-hydroxylase** is the rate-limiting step in bile acid synthesis (inhibited by bile acids via feedback). * **Conjugation:** Before secretion into bile, primary bile acids are conjugated with **Glycine** or **Taurine** (forming glycocholic acid, etc.) to increase their solubility at intestinal pH. * **Enterohepatic Circulation:** Approximately 95% of bile acids are reabsorbed in the **terminal ileum** and returned to the liver; only 5% are excreted in feces. * **Clinical Correlation:** Bile acid sequestrants (like Cholestyramine) lower LDL cholesterol by interrupting this circulation, forcing the liver to use more cholesterol to synthesize new bile acids.

Q: Which of the following is not a component of triglycerides?

Sphingosine. ### Explanation **1. Why Sphingosine is the Correct Answer:** Triglycerides (Triacylglycerols) are simple lipids composed of a **glycerol backbone** esterified to **three fatty acid chains**. **Sphingosine** is an 18-carbon amino alcohol that serves as the structural backbone for **sphingolipids** (such as sphingomyelin and glycosphingolipids), not triglycerides. In sphingolipids, a fatty acid attaches to the amino group of sphingosine to form a *ceramide*, which is the fundamental structural unit of that class. **2. Analysis of Incorrect Options:** * **A. Glycerol:** This is the 3-carbon alcohol backbone of all triglycerides. Each of its three hydroxyl (-OH) groups reacts with a fatty acid to form ester bonds. * **B. Linoleic Acid:** This is an essential polyunsaturated fatty acid (PUFA). Fatty acids like linoleic acid are common components that esterify with glycerol to form triglycerides. * **C. Palmitic Acid:** This is a 16-carbon saturated fatty acid. It is the most common fatty acid found in human triglycerides and is the primary product of the Fatty Acid Synthase (FAS) complex. **3. NEET-PG High-Yield Pearls:** * **Storage:** Triglycerides are the highly concentrated storage form of energy in adipose tissue because they are anhydrous and reduced. * **Linkage:** Triglycerides contain **ester bonds**, whereas sphingolipids contain **amide bonds** (linking the fatty acid to sphingosine). * **Clinical Correlation:** Elevated serum triglycerides (>1000 mg/dL) are a significant risk factor for **acute pancreatitis**. * **Niemann-Pick Disease:** A lysosomal storage disorder caused by a deficiency in sphingomyelinase, leading to the accumulation of sphingomyelin (a sphingosine-based lipid).

Q: Which of the following is a characteristic of dyslipidemia associated with alcohol consumption?

Increased HDL. **Explanation:** Alcohol consumption has a complex effect on lipid metabolism, primarily characterized by **increased synthesis of High-Density Lipoprotein (HDL)** and **Hypertriglyceridemia**. **Why "Increased HDL" is correct:** Moderate alcohol consumption stimulates the hepatic synthesis and secretion of **Apolipoprotein A-I and A-II**, which are the primary structural proteins of HDL. Additionally, alcohol inhibits the activity of **Cholesteryl Ester Transfer Protein (CETP)**. Since CETP normally transfers cholesterol from HDL to VLDL/LDL, its inhibition leads to higher circulating levels of HDL-cholesterol (HDL-C), often referred to as the "cardioprotective" effect of moderate drinking. **Analysis of Incorrect Options:** * **A. Decreased HDL:** Incorrect, as alcohol is one of the few substances known to consistently raise HDL levels. * **C. Decreased Triglycerides:** Incorrect. Alcohol increases the NADH/NAD+ ratio in hepatocytes, which inhibits fatty acid oxidation and promotes fatty acid synthesis. This leads to **increased VLDL production** and elevated plasma triglycerides. * **D. Decreased Lipoprotein Lipase (LPL):** Incorrect. Alcohol actually tends to **increase or maintain LPL activity** in adipose tissue and muscle to facilitate the clearance of chylomicrons, though this is often overwhelmed by the massive increase in VLDL production. **High-Yield Clinical Pearls for NEET-PG:** * **Alcoholic Fatty Liver:** Driven by an increased **NADH/NAD+ ratio**, which shifts metabolism toward lipogenesis. * **Type IV Hyperlipidemia:** Chronic alcohol abuse is a common secondary cause of elevated VLDL (Hypertriglyceridemia). * **Wolman Disease:** A differential for lipid storage, caused by Lysosomal Acid Lipase deficiency. * **HDL marker:** Apo A-I is the most specific marker for HDL particles.

Q: Lipoprotein A resembles which of the following?

Plasminogen. ### Explanation **Correct Option: A (Plasminogen)** Lipoprotein (a), often written as **Lp(a)**, consists of a Low-Density Lipoprotein (LDL) particle covalently linked to a unique glycoprotein called **Apolipoprotein (a)** via a disulfide bond. The structural hallmark of Apolipoprotein (a) is its high degree of homology with **Plasminogen**. Specifically, Apo(a) contains multiple repeats of "kringle domains" (Kringle IV and V) that are structurally similar to those found in plasminogen. Because of this structural mimicry, Lp(a) competes with plasminogen for binding sites on fibrin and endothelial cells. This competition inhibits the activation of plasminogen into plasmin, thereby **inhibiting fibrinolysis** (clot breakdown) and promoting a pro-thrombotic state. **Why other options are incorrect:** * **B. Plasmin:** Plasmin is the active serine protease derived from plasminogen. While Lp(a) resembles the precursor (plasminogen), it does not possess the enzymatic activity of plasmin. * **C & D. Thrombin/Prothrombin:** These are key components of the coagulation cascade (Factor IIa and II). They do not share the specific "kringle domain" structural homology characteristic of the Apo(a) protein. **High-Yield NEET-PG Pearls:** * **Atherothrombogenic Duo:** Lp(a) is uniquely dangerous because it is both **atherogenic** (due to its LDL component) and **thrombogenic** (due to its structural resemblance to plasminogen). * **Risk Factor:** Elevated levels of Lp(a) are an independent risk factor for premature coronary artery disease (CAD) and stroke. * **Genetics:** Lp(a) levels are primarily determined by genetics and are largely resistant to traditional diet and statin therapy. * **Niacin:** Historically, Niacin was one of the few drugs known to significantly lower Lp(a) levels.

Q: Which metabolite accumulates in Wolman's disease?

Cholesteryl ester. **Explanation:** **Wolman’s Disease** is a severe, autosomal recessive lysosomal storage disorder caused by a deficiency of the enzyme **Lysosomal Acid Lipase (LAL)**. 1. **Why Cholesteryl Ester is correct:** Under normal physiological conditions, LAL is responsible for hydrolyzing cholesteryl esters and triglycerides (delivered via LDL) into free cholesterol and free fatty acids within the lysosome. In Wolman’s disease, the absence of this enzyme leads to the massive accumulation of **cholesteryl esters** and **triglycerides** within the lysosomes of various tissues, particularly the liver, spleen, and adrenal glands. 2. **Why other options are incorrect:** * **Amino acids:** Accumulate in disorders of amino acid metabolism (e.g., Phenylketonuria or Maple Syrup Urine Disease), not lysosomal lipid storage. * **Sulfite:** Accumulates in Sulfite Oxidase Deficiency, a rare neurometabolic disorder. * **Glycogen:** Accumulates in Glycogen Storage Diseases (GSDs), such as Pompe disease (Type II), which is lysosomal but involves α-glucosidase deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Pathognomonic Sign:** Bilateral **adrenal calcification** is a classic radiological finding in Wolman’s disease (seen in ~50% of cases). * **Clinical Presentation:** Infants typically present with hepatosplenomegaly, steatorrhea, failure to thrive, and abdominal distension. * **Spectrum of Disease:** **Cholesteryl Ester Storage Disease (CESD)** is the milder, late-onset form of LAL deficiency, whereas Wolman’s is the severe, infantile-onset form. * **Treatment:** Enzyme replacement therapy with **Sebelipase alfa** is now available.

Question 1

Which of the following processes occurs during a low insulin to glucagon ratio?

Accepted Answer

Ketogenesis

Answer

Cholesterol synthesis

Answer

Glycogen synthesis

Answer

Fatty acid synthesis

Question 2

In which of the following metabolic disorders is this skin finding characteristically seen?

Accepted Answer

Fabry disease

Answer

Farber disease

Answer

Galactosemia

Answer

Albinism

Question 3

Which of the following classes of lipoproteins transfers cholesterol from membrane turnover?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

IDL

Question 4

Long chain fatty acids penetrate the inner mitochondrial membrane as:

Accepted Answer

Carnitine derivatives

Answer

Pyruvate

Answer

Acetyl CoA derivatives

Answer

Acyl CoA

Question 5

Which of the following is a secondary bile acid?

Accepted Answer

Litocholic acid

Answer

Cholic acid

Answer

Chenodeoxycholic acid

Answer

None of the above

Question 6

Which of the following is not a component of triglycerides?

Accepted Answer

Sphingosine

Answer

Glycerol

Answer

Linoleic acid

Answer

Palmitic acid

Question 7

Which of the following is considered the regulated step in steroid hormone synthesis in the zona fasciculata?

Accepted Answer

Cholesterol to pregnenolone

Answer

Corticosterone to aldosterone

Answer

11-Deoxycortisol to cortisol

Answer

Pregnenolone to progesterone

Question 8

Which of the following is a characteristic of dyslipidemia associated with alcohol consumption?

Accepted Answer

Increased HDL

Answer

Decreased HDL

Answer

Decreased triglycerides

Answer

Decreased lipoprotein lipase

Question 9

Lipoprotein A resembles which of the following?

Accepted Answer

Plasminogen

Answer

Plasmin

Answer

Thrombin

Answer

Prothrombin

Question 10

Which metabolite accumulates in Wolman's disease?

Accepted Answer

Cholesteryl ester

Answer

Amino acid

Answer

Sulfite

Answer

Glycogen

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?